Newsroom

Sorted by: Latest

-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 01 October 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, an...
-

Melqart Asset Management UK Regulatory Announcement: Form 8.3 Mitie Group PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)     1 KEY INFORMATION   (a) Full name of discloser: MELQART ASSET MANAGEMENT (UK) LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and benefic...
-

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ

CHICAGO & STOCKHOLM--(BUSINESS WIRE)--Tacton appoints Merlin Knott as Chief Commercial Officer to lead its global commercial organization and accelerate growth beyond CPQ....
-

Palleon Pharmaceuticals Announces Late-Breaking Oral Presentation on HLX79/E-602 in Autoimmune Disease at the 2026 American Society of Nephrology (ASN) Kidney Week

WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics for autoimmunity and cancer, will deliver a late-breaking oral presentation at the 2026 American Society of Nephrology (ASN) Kidney Week, taking place October 21-25 in Denver, Colorado. Palleon’s presentation will take place on Friday, October 23. Details of Palleon’s Presentation: American Society of Nephrology (ASN) Kidney Week Title: HLX79 (E-602) Plus Rituximab Prod...
-

Two Credit Unions. One Stronger Future. Sky Federal Credit Union and On Tap Credit Union Announce Intent to Merge

GOLDEN, Colo. & LIVINGSTON, Mont.--(BUSINESS WIRE)--Sky Federal Credit Union and On Tap Credit Union today announced their intent to pursue a merger, bringing together two financially strong, community-focused credit unions with a shared commitment to members, employees, and the communities they call home.Both credit unions are financially healthy and well-positioned for the future. This merger of peers is a strategic decision by two strong organizations to bring together complementary resources...
-

Business Wire Celebrates 65 Years of Trusted Press Release Distribution

SAN FRANCISCO--(BUSINESS WIRE)--Business Wire celebrates 65 years of global press release distribution and regulatory disclosure, highlighting its history and continued innovation....
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust...
-

Millennium Partners, L.P. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...